Takeshi Yamasaki

Osaka Metropolitan University, Osaka City University

Papers

7

Total Citations

45

H-Index

4

About

Dr. Takeshi Yamasaki is a leading urological surgeon whose research focuses on optimizing robot-assisted surgical techniques for prostate and kidney cancers. His major contributions center on the critical role of pelvic lymph node dissection (PLND) in high-risk prostate cancer, where he has led multi-institutional studies and co-authored the Japanese expert consensus standardizing robot-assisted PLND. His work has generated over 45 citations, with his 2024 consensus paper alone accumulating 13 citations. Dr. Yamasaki has also pioneered the simultaneous robotic-assisted partial nephrectomy for bilateral renal tumors and investigated the non-renorrhaphy technique for highly complex renal tumors (RENAL score ≥10), demonstrating innovative approaches to maximize functional preservation. His recent comparative studies on neoadjuvant hormonal and chemohormonal therapies versus extended PLND in high-risk prostate cancer patients undergoing robot-assisted radical prostatectomy provide crucial evidence for treatment decision-making. Through his multicenter retrospective analyses using propensity score matching, Dr. Yamasaki continues to shape the evidence base for urological oncology, balancing curative surgery with functional outcomes.

Research Focus

Key Achievements

4
H-Index
7
Papers
45
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Japanese expert consensus on the standardization of robot‐assisted pelvic lymph node dissection in urological surgery: Extent of pelvic lymph node and surgical technique
13 citations · 2024
📈 Most Prolific Year: 2025 (3 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Osaka Metropolitan University, Osaka City University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago